In the BioHarmony Drug Report Database

"Preview" Icon

Mechlorethamine

Mustargen, Valchlor, Ledaga (mechlorethamine) is a small molecule pharmaceutical. Mechlorethamine was first approved as Mustargen on 1982-01-01. It is used to treat hodgkin disease, malignant pleural effusion, mycosis fungoides, and neoplasm metastasis in the USA. It has been approved in Europe to treat mycosis fungoides. Valchlor’s patents are valid until 2029-07-08 (FDA).

 

Trade Name

 

Ledaga
 

Common Name

 

mechlorethamine
 

ChEMBL ID

 

CHEMBL427
 

Indication

 

hodgkin disease, malignant pleural effusion, mycosis fungoides, neoplasm metastasis
 

Drug Class

 

Image (chem structure or protein)

Mechlorethamine structure rendering